SENP3 and metabolic dysfunction-associated steatotic liver disease: To verify if SENP3 contributes to the development of NAFLD, SENP3 was either silenced with SENP3-siRNA (Supplementary Figure 3C) or overexpressed with a GFP-SENP3 plasmid (Supplementary Figure 3D) in hepatocytes in vitro.